Acutaas Chemicals Ltd

Acutaas Chemicals Ltd

$ACUTAASPharmaceuticalsNSEBSE

Acutaas Chemicals Ltd (ACUTAAS) last traded at ₹3,302, a market capitalisation of ₹27,034 crore, on a P/E of 70.0. Over the past 52 weeks the stock has ranged between ₹1,290 and ₹3,740. Acutaas Chemicals Ltd last reported results for the quarter ended Jun 2026, with sales of ₹330 crore and net profit of ₹75 crore. Acutaas Chemicals Ltd’s annual general meeting is scheduled for 24 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.

Acutaas Chemicals Ltd share price and key metrics

Current price
₹3,302
Market cap
₹27,034 cr
Stock P/E
70.0
Book value
₹202
ROE
24.0%
ROCE
31.6%
Dividend yield
0.05%
52w high / low
3740/1290

Metrics as of 25 Aug 2026. Not real time.

Acutaas Chemicals Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹330 cr, up 59.4% from ₹207 cr a year earlier. Net profit was ₹75 cr, up 70.5% year on year.

Acutaas Chemicals Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales247275308207306393433330
Expenses198206224156211243249217
Operating profit4969855195151184113
OPM %20%25%28%25%31%38%42%34%
Other income82616105112
Interest01111111
Depreciation76788101010
Profit before tax5063835896145184104
Tax %25%28%24%24%25%27%27%28%
Net profit384563447210613475
EPS (₹)4.565.497.635.418.8213.1916.099.07

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Acutaas Chemicals Ltd annual results

Acutaas Chemicals Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales3415206177171,0071,3391,462
Operating profit80105123128232480543
OPM %24%20%20%18%23%36%37%
Net profit54728349160356387
EPS (₹)8.579.8711.435.8019.3843.5147.17

TTM is the trailing twelve months to the most recent quarter.

Acutaas Chemicals Ltd growth and returns

Compounded Sales Growth
10 Years
%
5 Years
32%
3 Years
30%
TTM
41%
Compounded Profit Growth
10 Years
%
5 Years
46%
3 Years
62%
TTM
104%
Stock Price CAGR
10 Years
%
5 Years
%
3 Years
68%
1 Year
122%
Return on Equity
10 Years
20%
5 Years
18%
3 Years
18%
Last Year
24%

Acutaas Chemicals Ltd shareholding pattern

Promoters held 32.66% at Jun 2026, broadly unchanged since Jun 2025. FIIs 21.61% and DIIs 19.55%.

Acutaas Chemicals Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters35.97%35.96%35.96%32.66%32.66%32.66%32.66%32.66%
FIIs13.87%15.52%16.48%16.94%16.84%16.67%19.48%21.61%
DIIs19.93%20.23%18.31%22.38%22.59%21.70%19.60%19.55%
Government0.00%0.01%0.01%0.01%0.01%0.01%0.01%0.01%
Public30.24%28.27%29.22%28.00%27.89%28.96%28.24%26.16%
No. of shareholders93,39495,7561,14,0601,19,8901,08,6641,10,3631,12,9391,25,569

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

Cruxal coverage of Acutaas Chemicals Ltd

When is Acutaas Chemicals Ltd’s AGM?

Acutaas Chemicals Ltd’s annual general meeting is scheduled for 24 Sept 2026.

  • AGM19th Annual General Meeting

See the full results calendar for every Indian company reporting in the next 30 days.

Acutaas Chemicals Ltd corporate filings

  • Newspaper Publication in respect of 19th AGM of the company scheduled to be held on Thursday, September 24, 2026 is attachedCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Acutaas Chemicals Limited has issued an intimation regarding its 19th Annual General…

    Read the full analysis
  • Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 is attached.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Acutaas Chemicals Ltd has submitted a routine intimation under Regulation 30 of the SEBI…

    Read the full analysis
  • We wish to inform you that, Ministry of Electronics and Information Technology has accorded its approval for the incentive package under the ECMS scheme as per the details attachedCompany Updatemedium impact
    Filing PDF

    Cruxal's analysis: Acutaas Chemicals Ltd has received formal approval from the Ministry of Electronics and…

    Read the full analysis
  • Schedule of Investor Meet is attached.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Acutaas Chemicals Ltd has issued an intimation regarding a scheduled analyst/investor…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Acutaas Chemicals Ltd

Cruxal reads every Acutaas Chemicals Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.

Acutaas Chemicals Ltd (ACUTAAS) Results, Financials & Share Price | Cruxal